These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30969421)

  • 21. The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.
    Peterson YK; Luttrell LM
    Pharmacol Rev; 2017 Jul; 69(3):256-297. PubMed ID: 28626043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
    Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
    Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new inhibitor of the β-arrestin/AP2 endocytic complex reveals interplay between GPCR internalization and signalling.
    Beautrait A; Paradis JS; Zimmerman B; Giubilaro J; Nikolajev L; Armando S; Kobayashi H; Yamani L; Namkung Y; Heydenreich FM; Khoury E; Audet M; Roux PP; Veprintsev DB; Laporte SA; Bouvier M
    Nat Commun; 2017 Apr; 8():15054. PubMed ID: 28416805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular Assay to Study β-Arrestin Recruitment by the Cannabinoid Receptors 1 and 2.
    Bouma J; Soethoudt M; van Gils N; Xia L; van der Stelt M; Heitman LH
    Methods Mol Biol; 2023; 2576():189-199. PubMed ID: 36152187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics.
    Xiao K; Sun J
    Cell Signal; 2018 Jan; 41():56-64. PubMed ID: 28939107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors.
    Verkaar F; van Rosmalen JW; Blomenröhr M; van Koppen CJ; Blankesteijn WM; Smits JF; Zaman GJ
    Biotechnol Annu Rev; 2008; 14():253-74. PubMed ID: 18606367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arrestin recruitment and signaling by G protein-coupled receptor heteromers.
    Mores KL; Cassell RJ; van Rijn RM
    Neuropharmacology; 2019 Jul; 152():15-21. PubMed ID: 30419245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biased Signaling through G Protein-coupled Receptors].
    Kurose H
    Yakugaku Zasshi; 2022; 142(10):1091-1101. PubMed ID: 36184444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential.
    Seyedabadi M; Ghahremani MH; Albert PR
    Pharmacol Ther; 2019 Aug; 200():148-178. PubMed ID: 31075355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscarinic receptor regulates extracellular signal regulated kinase by two modes of arrestin binding.
    Jung SR; Kushmerick C; Seo JB; Koh DS; Hille B
    Proc Natl Acad Sci U S A; 2017 Jul; 114(28):E5579-E5588. PubMed ID: 28652372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring β-arrestin recruitment via β-lactamase enzyme fragment complementation: purification of peptide E as a low-affinity ligand for mammalian bombesin receptors.
    Ikeda Y; Kumagai H; Okazaki H; Fujishiro M; Motozawa Y; Nomura S; Takeda N; Toko H; Takimoto E; Akazawa H; Morita H; Suzuki J; Yamazaki T; Komuro I; Yanagisawa M
    PLoS One; 2015; 10(6):e0127445. PubMed ID: 26030739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Super-Resolution Imaging of G Protein-Coupled Receptors Using Ground State Depletion Microscopy.
    Caetano Crowley FA; Heit B; Ferguson SSG
    Methods Mol Biol; 2019; 1947():323-336. PubMed ID: 30969425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tango assay for ligand-induced GPCR-β-arrestin2 interaction: Application in drug discovery.
    Dogra S; Sona C; Kumar A; Yadav PN
    Methods Cell Biol; 2016; 132():233-54. PubMed ID: 26928547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of the Tango beta-arrestin recruitment technology for cell-based EDG receptor assay development and interrogation.
    Wetter JA; Revankar C; Hanson BJ
    J Biomol Screen; 2009 Oct; 14(9):1134-41. PubMed ID: 19726785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiling of basal and ligand-dependent GPCR activities by means of a polyvalent cell-based high-throughput platform.
    Zeghal M; Laroche G; Freitas JD; Wang R; Giguère PM
    Nat Commun; 2023 Jul; 14(1):3684. PubMed ID: 37407564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands.
    Leduc M; Breton B; Galés C; Le Gouill C; Bouvier M; Chemtob S; Heveker N
    J Pharmacol Exp Ther; 2009 Oct; 331(1):297-307. PubMed ID: 19584306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Split luciferase-based assay for simultaneous analyses of the ligand concentration- and time-dependent recruitment of β-arrestin2.
    Littmann T; Buschauer A; Bernhardt G
    Anal Biochem; 2019 May; 573():8-16. PubMed ID: 30853375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catalytic activation of β-arrestin by GPCRs.
    Eichel K; Jullié D; Barsi-Rhyne B; Latorraca NR; Masureel M; Sibarita JB; Dror RO; von Zastrow M
    Nature; 2018 May; 557(7705):381-386. PubMed ID: 29720660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The wonderful and masterful G protein-coupled receptor (GPCR): A focus on signaling mechanisms and the neuroendocrine control of fertility.
    Babwah AV
    Mol Cell Endocrinol; 2020 Sep; 515():110886. PubMed ID: 32574585
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.